http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100944037-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2007-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100944037-B1 |
titleOfInvention | Cysteine deoxygenase, lung cancer treatment including recombinant vector containing type I gene |
abstract | The present invention relates to a lung cancer therapeutic agent using a recombinant vector containing a cysteine dioxygenase, a type I (cysteine dioxygenase, type I, CDO1 ) encoding gene, and more specifically, the promoter site in lung cancer cells specifically The present invention relates to a lung cancer therapeutic agent that inhibits the proliferation of lung cancer cells by introducing a recombinant vector containing cysteine deoxygenase and a gene encoding a type I gene, which is methylated and whose expression of the gene is significantly reduced.n n n According to the present invention, treatment of lung cancer cells with a recombinant vector containing the cysteine deoxygenase, a gene encoding type I, inhibits the proliferation of lung cancer cells and is useful for treating lung cancer.n n n n Cysteine deoxygenase type I gene, methylation, lung cancer |
priorityDate | 2007-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 208.